ANCA ASSOCIATED VASCULITIS
Clinical trials for ANCA ASSOCIATED VASCULITIS explained in plain language.
Never miss a new study
Get alerted when new ANCA ASSOCIATED VASCULITIS trials appear
Sign up with your email to follow new studies for ANCA ASSOCIATED VASCULITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Off-the-Shelf' cell therapy trial targets six severe autoimmune diseases
Disease control Not yet recruitingThis early-stage study is testing a new cell therapy called BCT301 for people with severe autoimmune diseases that haven't responded to standard treatments. The therapy uses lab-made immune cells designed to target and remove harmful B cells, which are thought to drive these dise…
Matched conditions: ANCA ASSOCIATED VASCULITIS
Phase: EARLY_PHASE1 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Scientists hunt rogue cells behind devastating autoimmune attacks
Knowledge-focused Not yet recruitingThis French study aims to better understand how autoimmune diseases like lupus and scleroderma start. Researchers will analyze blood samples from 200 patients to identify and measure specific 'rogue' immune cells that mistakenly attack the body. The goal is to gather knowledge ab…
Matched conditions: ANCA ASSOCIATED VASCULITIS
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:24 UTC